Filing Details
- Accession Number:
- 0001209191-19-003072
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2019-01-09 16:48:43
- Reporting Period:
- 2019-01-03
- Accepted Time:
- 2019-01-09 16:48:43
- Original Submission Date:
- 2019-01-07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1731164 | Cecily Alison Finger | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-01-03 | 120 | $98.32 | 15,547 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-03 | 228 | $99.27 | 15,319 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-03 | 128 | $100.32 | 15,191 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- The range in prices for the transaction reported on this line was $98.07 to $98.845. The average weighted price was $98.3155. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $99.08 to $99.805. The average weighted price was $99.2721. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
